Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127342192 | 12734219 | 2 | F | 201608 | 20160902 | 20160912 | 20160923 | EXP | BR-009507513-1609BRA002111 | MERCK | 38.00 | YR | F | Y | 73.00000 | KG | 20160923 | OT | BR | BR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127342192 | 12734219 | 1 | PS | NUVARING | ETHINYL ESTRADIOLETONOGESTREL | 1 | Vaginal | UNK | Y | 115660 | 21187 | VAGINAL RING | |||||||
127342192 | 12734219 | 2 | SS | IMPLANON | ETONOGESTREL | 1 | Subdermal | UNK | 0 | IMPLANT | |||||||||
127342192 | 12734219 | 3 | SS | IMPLANON | ETONOGESTREL | 1 | Subdermal | UNK | 0 | IMPLANT | |||||||||
127342192 | 12734219 | 4 | C | DEPAKOTE ER | DIVALPROEX SODIUM | 1 | Oral | 300 MG (2 TABLETS), EVERY 8 HOURS | 0 | 300 | MG | TABLET | Q8H | ||||||
127342192 | 12734219 | 5 | C | DEPAKOTE ER | DIVALPROEX SODIUM | 1 | 0 | TABLET | |||||||||||
127342192 | 12734219 | 6 | C | RIVOTRIL | CLONAZEPAM | 1 | Oral | 2 MG (1 TABLET), EVERY 8 HOURS | 0 | 2 | MG | TABLET | Q8H | ||||||
127342192 | 12734219 | 7 | C | RIVOTRIL | CLONAZEPAM | 1 | 0 | TABLET | |||||||||||
127342192 | 12734219 | 8 | C | DONAREN | TRAZODONE HYDROCHLORIDE | 1 | Oral | 300 MG (2 TABLETS), DAILY | 0 | 300 | MG | TABLET | |||||||
127342192 | 12734219 | 9 | C | ARIPIPRAZOLE. | ARIPIPRAZOLE | 1 | Oral | 10 MG, 1 TABLET DAILY | 0 | 10 | MG | TABLET | QD | ||||||
127342192 | 12734219 | 10 | C | ARIPIPRAZOLE. | ARIPIPRAZOLE | 1 | 0 | TABLET | |||||||||||
127342192 | 12734219 | 11 | C | CONCOR | BISOPROLOL FUMARATE | 1 | Oral | ONE TABLET, EVERY 12 HOURS | 0 | 1 | DF | TABLET | Q12H | ||||||
127342192 | 12734219 | 12 | C | CONCOR | BISOPROLOL FUMARATE | 1 | 0 | TABLET | |||||||||||
127342192 | 12734219 | 13 | C | CONCOR | BISOPROLOL FUMARATE | 1 | 0 | TABLET |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127342192 | 12734219 | 1 | Ovarian cyst |
127342192 | 12734219 | 2 | Contraception |
127342192 | 12734219 | 4 | Bipolar disorder |
127342192 | 12734219 | 5 | Panic disorder |
127342192 | 12734219 | 6 | Bipolar disorder |
127342192 | 12734219 | 7 | Panic disorder |
127342192 | 12734219 | 8 | Depression |
127342192 | 12734219 | 9 | Hallucination |
127342192 | 12734219 | 10 | Intentional self-injury |
127342192 | 12734219 | 11 | Supraventricular tachycardia |
127342192 | 12734219 | 12 | Dizziness |
127342192 | 12734219 | 13 | Syncope |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127342192 | 12734219 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127342192 | 12734219 | Appendicitis | |
127342192 | 12734219 | Hypomenorrhoea | |
127342192 | 12734219 | Overdose | |
127342192 | 12734219 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127342192 | 12734219 | 1 | 20160827 | 20160828 | 0 | |
127342192 | 12734219 | 2 | 20131023 | 0 | ||
127342192 | 12734219 | 3 | 2004 | 0 |